NDUFAF3
protein-codingNADH:ubiquinone oxidoreductase complex assembly factor 3, the group of Mitochondrial respiratory chain complex assembly factors
Gene summary
This gene encodes a mitochondrial complex I assembly protein that interacts with complex I subunits. Mutations in this gene cause mitochondrial complex I deficiency, a fatal neonatal disorder of the oxidative phosphorylation system. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2009]
- C3orf60
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~3.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0100133
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0032623
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *NDUFAF3* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of March 7, 2022. The *NDUFAF3* gene (previously known as *C3ORF60*) encodes the NADH:ubiquinone oxidoreductase (complex I) assembly factor 3. Defects of this protein lead to complex I deficiency. The *NDUFAF3* gene was first reported in relation to autosomal recessive primary mitochondrial disease in 2009 (PMID: 19463981), in three unrelated families with severe neonatal lactic acidosis. While various names have been given to the constellation of features seen in those with *NDUFAF3*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *NDUFAF3* phenotype has been lumped into one disease entity according to per the ClinGen Lumping and Splitting Framework. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included six variants (four missense, one initiation codon, one in-frame duplication) in five cases from three publications (PMIDs: 19463981, 27986404, 29344937). Affected individuals typically presented in the neonatal period to early childhood and clinical features include Leigh syndrome spectrum (LSS), neonatal lactic acidosis, developmental regression, hypotonia, myoclonic seizures, and optic atrophy. Respiratory chain enzyme activity assays in muscle and fibroblasts revealed complex I deficiency. Loss of function resulting in a complex I assembly defect is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function and model systems in *Caenorhabditis elegans* and *Drosophila melanogaster* (PMIDs: 27509854, 22387847, 34386730). In summary, there is definitive evidence to support this gene-disease relationship, including that more than three years have elapsed since the first proposal of the association. No convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on March 7, 2022 (SOP Version 8).
Inheritance Pattern: AR
Disease ID:MONDO:0032623
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032623
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Gastrointestinal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Medical treatment (eg, riboflavin, ubiquinol) may be beneficial; Individuals may have cardiac involvement
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NDUFAF3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_199069.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 22 | 25 | |||
| missense | 3 | 1 | 50 | 7 | 61 | |
| nonsense | 2 | 1 | 3 | |||
| start loss | 1 | 1 | ||||
| frameshift | 4 | 1 | 5 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 5 | 7 | 56 | 29 | 0 | 97 |
Highest pathogenic variant AF is 0.0001511699
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_951032.1 | 5 | MANE Select | |
| Ensembl | ENSP00000323076.5 | 5 | MANE Select | |
| RefSeq | NP_951033.1 | 4 | Standard | |
| RefSeq | NP_951047.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thermogenesis - Homo sapiens (human)
- Respiratory electron transport
- The citric acid (TCA) cycle and respiratory electron transport
- Metabolism
- Complex I biogenesis
Biological Process
- mitochondrial respiratory chain complex I assembly
Molecular Function
- protein binding
Cellular Component
- nucleus
- mitochondrial inner membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000326925
- Coding exons
- 5
- Length
- 3037
- Individuals with no LoFs
- 125700
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 48
- Defined
- 125748
- p
- 0.000191
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.494 | 120 | 106 | 1.14 | 0.00000520 | 1150 |
| Missense (PolyPhen) | 47 | 39.436 | 1.1918 | 459 | ||
| Synonymous | -0.472 | 49 | 45.0 | 1.09 | 0.00000216 | 407 |
| Loss of Function | 1.43 | 5 | 9.85 | 0.508 | 4.40e-7 | 91 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00032 | 0.00031 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0.0024 | 0.0024 | notable |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000053 | 0.000046 | rare |
| European (Non-Finnish) | 0.000089 | 0.000088 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Essential factor for the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). {ECO:0000269|PubMed:19463981}.;
- Disease
- DISEASE: Mitochondrial complex I deficiency (MT-C1D) [MIM:252010]: A disorder of the mitochondrial respiratory chain that causes a wide range of clinical manifestations from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. {ECO:0000269|PubMed:19463981}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- LoFtool
- 0.404
- RVIS EVS
- -0.25
- RVIS percentile EVS
- 35.42
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.860
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |